Tag : Precision Oncology

Digital Health, Technology & Innovation

Personalis Publishes Evidence on Ultrasensitive ctDNA Monitoring

Business Wire
by Business Wire052
Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today announced the publication of a new study in npj Precision Oncology highlighting the power...
Clinical Research, Pharma & Healthcare Financing

Agendia MammaPrint Guides Anthracycline Use in Early Breast Cancer

Business Wire
by Business Wire040
Update based on real-world evidence from the FLEX Study presented at the 2025 San Antonio Breast Cancer Symposium Agendia, Inc., a leader in precision oncology...